Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS). Braz. J. Pharm. Sci. [Internet]. 2022 Dec. 23 [cited 2024 Jun. 26];58. Available from: https://revistas.usp.br/bjps/article/view/205627